Patricia Franchi Selected Research

Patricia Franchi Research Topics

5	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 04/2011
2	Multiple Myeloma 10/2022 - 08/2021
2	Lymphoma (Lymphomas) 03/2018 - 01/2018
1	Philadelphia Chromosome 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2014
1	Febrile Neutropenia 04/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2010
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2010
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2010

2	Brentuximab VedotinIBA 01/2022 - 07/2014
2	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 04/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 08/2010
2	Rituximab (Mabthera)FDA Link 01/2018 - 08/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 07/2015 - 04/2011
1	COVID-19 VaccinesIBA 10/2022
1	Monoclonal AntibodiesIBA 08/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 09/2013
1	Dacarbazine (DIC)FDA LinkGeneric 04/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2011
1	Ifosfamide FDA LinkGeneric 04/2011
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2011
1	N 30IBA 08/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2010
1	tipifarnib (R115777)IBA 03/2010
1	Farnesyltranstransferase (Farnesyltransferase)IBA 03/2010

6	Therapeutics 10/2022 - 08/2010
3	Drug Therapy (Chemotherapy) 01/2019 - 04/2011
2	Stem Cell Transplantation 01/2022 - 08/2010
1	Drug Tapering 04/2011
1	Combination Drug Therapy (Combination Chemotherapy) 08/2010
1	Salvage Therapy 08/2010